This study shows that integrating plasma proteomics with multi-organ imaging provides a comprehensive pan-organ imaging-proteomics map and reveals molecular pathways linking circulating proteins to human organ biology.
Abstract
Plasma protein levels provide important insights into human disease, yet a comprehensive assessment of plasma proteomics across organs is lacking. Using large-scale multimodal data from the UK Biobank, we integrate plasma proteomics with organ imaging to map their phenotypic and genetic links, analyzing 2923 proteins and 1051 imaging traits across multiple organs. We uncover 5067 phenotypic protein-imaging associations, identifying both organ-specific and organ-shared proteomic relations, along with enriched protein-protein interaction networks and biological pathways. Sensitivity analyses suggest that these associations are not substantially influenced by the median 10.18-year interval between plasma sampling and imaging visits. We also map key protein predictors of organ structures and show the stratification capability of plasma protein-based prediction models. Furthermore, we identify 8116 putative causal protein-imaging links. Imaging-associated protein components show enrichment across diverse complex diseases. Our study shows that integrating plasma proteomics with multi-organ imaging provides a comprehensive pan-organ imaging-proteomics map and reveals molecular pathways linking circulating proteins to human organ biology. Fan and colleagues present a study where they map links between plasma proteins and imaging traits across multiple human organs, revealing organ-specific and cross-organ protein signatures, predictive biomarkers, and genetic evidence supporting causal protein-imaging relationships.
It is demonstrated how untargeted nanoparticle-enriched mass spectrometry (MS)-based plasma proteomics delivers quantitatively and qualitatively different insights compared to two affinity-based assays in a sample of ~1,400 British South Asian individuals.
M. Pietzner, A. Williamson, K. Hunt et al.· Nature Genetics· 2 citations
The absence of robust biomarkers for early detection of severe liver disease (SLD) highlights the critical need for high-throughput proteomics-driven discovery. In this prospective cohort study, we aimed to identify plasma protein signatures associated with incident SLD and assess their clinical utility. Using the larg...
Circulating plasma proteins are key biomarkers and therapeutic targets, now measurable at scale through high-throughput technologies, yet whether expanding proteomics platforms beyond the classical plasma secretome enhances genetic discovery and causal inference remains poorly understood. Here, we use an expanded SomaS...
S. Cadiou, E. Konig, A. Mapelli et al.· medRxiv· 0 citations
Conventional univariate reference intervals (UniRIs) are widely used to identify abnormal biomarker values, but they evaluate each biomarker independently and do not account for coordinated deviations between biomarkers. We developed and evaluated a joint reference region (JRR) framework for plasma proteomics data usin...
M. Pusparum, O. Thas, G. Ertaylan· medRxiv· 0 citations
Abdominal aortic aneurysm (AAA) is a progressive and often asymptomatic vascular disease associated with high mortality after rupture, but reliable circulating biomarkers for noninvasive detection remain limited. We aimed to identify and validate plasma protein biomarkers for AAA using an integrated proteomics-based ap...
Hui-Bo Ma, Jian-Hang Gao, Yi-Hang Cai et al.· International Journal of Mol...· 0 citations
Deep proteomic profiling of human carotid plaques identifies molecular signatures of symptomatic atherosclerosis that extend beyond conventional histopathology, which implicate neutrophil activation and inflammatory signaling pathways as key determinants of plaque vulnerability.
L. Zhang, L. Živković, A. Ray et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.